Fractyl Health, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Fractyl Health, Inc. (GUTS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 41.24 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-10
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 41.24M shares, a 263.73% increase year-over-year.
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 41.53M shares, a 268.29% increase year-over-year.
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 55.14M shares, a 380.54% increase year-over-year.
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 11.34M shares, a 2.23% decline year-over-year.
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 40.82M shares, a 288.36% increase from fiscal 2024.
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 10.51M shares, a 77.10% decline from fiscal 2023.
- Fractyl Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 45.89M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 41.24M shares 10-Q · filed 2026-08-10 | 41.24M shares 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | 41.53M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 40.82M shares 10-K · filed 2026-03-24 | |||
| 2025-09-30 | 55.14M shares 10-Q · filed 2025-11-12 | 55.14M shares 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 11.34M shares 10-Q · filed 2026-08-10 | 11.34M shares 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | 11.28M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 10.51M shares 10-K · filed 2026-03-24 | |||
| 2024-09-30 | 11.48M shares 10-Q · filed 2025-11-12 | 11.48M shares 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | 11.60M shares 10-Q · filed 2025-08-12 | 11.60M shares 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | 11.40M shares 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 45.89M shares 10-K · filed 2025-03-03 | |||
| 2023-09-30 | 45.46M shares 10-Q · filed 2024-11-12 | 45.46M shares 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | 45.46M shares 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | 45.48M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |